Pregnancy associated cardiomyopathy in 2 cancer survivors with history of anthracycline use
Ramy Zughul, Navya Akula, Isaac Rhea, Michael Zacharias, Heather Blume, Chantal ElAmm

TL;DR
This paper reports two cases of pregnancy-related heart disease in cancer survivors who previously used anthracyclines.
Contribution
It highlights a rare occurrence of new-onset cardiomyopathy in cancer survivors during pregnancy.
Findings
Pregnancy-associated cardiomyopathy occurred in two cancer survivors with prior anthracycline exposure.
New-onset cardiomyopathy is rare but possible in this high-risk population.
Abstract
Cardiac complications in childhood cancer survivors are increasingly recognized, with radiotherapy and anthracycline exposure being major culprits. The incidence of recurrent cardiomyopathy in this population is significant, while the incidence of new-onset cardiomyopathy remains rare. This case series presents two cases of pregnancy-associated cardiomyopathy with a history of anthracycline use.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChemotherapy-induced cardiotoxicity and mitigation · Cardiovascular Issues in Pregnancy · Ferrocene Chemistry and Applications
